MeSH tree: C04.588.894.797
A first-in-human Phase I study of SHR-4849 (IDE849), a Delta-like ligand 3 (DLL3)-directed antibody-drug conjugate (ADC), demonstrated manageable safety and early signs of anti-tumor activity in patients with relapsed small ...
Sep 7, 2025
0
29
Large cell neuroendocrine carcinoma (LCNEC), a rare and aggressive type of lung cancer, has a high chance of metastasis, no standard treatment and a poor survival rate. A study published in Nature Communications provides ...
Aug 20, 2025
0
17
New research from Dana-Farber Cancer Institute shows that a new class of drug results in cell death in cancers, such as small cell lung cancer, with a disabled quality control cell cycle checkpoint known as the G1/S checkpoint. ...
Aug 20, 2025
0
41
Adding a MET gene inhibitor enhances the effect of combined chemotherapy and immunotherapy in small cell lung cancer (SCLC), according to a multicenter study led by the Hospital del Mar Research Institute, in collaboration ...
Aug 12, 2025
0
25
One in two Australians regularly use artificial intelligence (AI), with that number expected to grow. AI is showing up in our lives more prominently than ever, with the arrival of ChatGPT and other chatbots.
Aug 10, 2025
0
35
New research has revealed that perilipin 2 protein modulates aggressive cancer progression in advanced lung adenocarcinoma, the most common type of lung cancer, by regulating lipid droplet accumulation, which plays an important ...
Aug 5, 2025
0
16
The possibility of having a tool that facilitates population screening for Chronic Obstructive Pulmonary Disease (COPD) is getting closer. A multicenter study involving leading hospitals across Spain, led by Hospital del ...
Aug 5, 2025
0
11
By analyzing tens of thousands of genes, proteins, and protein modifications in hundreds of lung tumors, an international research team has uncovered new factors linked to poor outcomes in lung adenocarcinoma in both smokers ...
Jul 31, 2025
0
27
Firefighters work hard saving lives, and in the process put their own lives at heightened risk from skin, kidney and other types of cancers, a new American Cancer Society (ACS) study finds.
Jul 30, 2025
0
14
A research team has developed a technology that distinguishes lung cancer gene mutations solely by measuring the "stiffness" of exosomes—tiny particles released from cancer cells in the bloodstream—using atomic force microscopy ...
Jul 30, 2025
0
18
